alternatives to glp 1 drugs GLP-1 for Employers GLP-1 Drug Savings: A Complete

Eye (Lond) 33(3):478485 Daniels AB et al (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)

The future of pemvidutide (and by extension Altimmune) rests on future trials showing weight reductions that match Wegovy or replicating NASH improvement trends from the Phase 1b (no small feat)

The same goes for people with a condition called gastroparesis, which affects stomach nerves and muscles, and those susceptible to medullary thyroid cancer

Drucker, Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease, Endocrine Reviews, 2023, 44, 1432

Truncated glucagon-like peptide-1 (proglucagon 78-107 amide), an intestinal insulin-releasing peptide, has specific receptors on rat insulinoma cells (RIN 5AH) FEBS Letters